Somebody really needs to take a look at the way these drugs are labelled by the mfgr.  A black box warning on a drug should require special labelling flags on the bulk packages.  A manufacturer has to assume the lowest common denominator in the hirelings behind the counter and that patients will consume what they are given without further scrutiny.  Is the manufacturer a defendant? Where is the FDA in all of this?  It is a clear cut case of adulteration!

From what I have seen, in these giant corporate stores you are pretty likely to have difficultly communicating with the techs and pharmacists as many have difficulty with English as a second language, both spoken and written because hiring is a matter of bodies for the buck, not qualification.  Not surprising it impacts the prescribing practice as well.  We need more of these litigations to succeed with giant judgements to put the CEO's on notice that their bonuses are at risk if they don't put qualified people on the front line.